Successful Treatment of Recalcitrant Ungual Wart with Tuberculin Purified Protein Derivative Immunotherapy
Malaysian Journal of Dermatology
;
: 33-36, 2022.
Article
in English
| WPRIM
| ID: wpr-962104
ABSTRACT
Summary@#Despite a variety of therapeutic options that is available, treatment of warts remains challenging and rate of recurrence is high. Intralesional immunotherapy is an emerging therapy for warts. Tuberculin purified protein derivative (PPD) is one of the immunotherapeutic antigens used for the treatment of warts. Here we report a case of recalcitrant periungual wart successfully treated with tuberculin immunotherapy.
Search on Google
Index:
WPRIM (Western Pacific)
Language:
English
Journal:
Malaysian Journal of Dermatology
Year:
2022
Type:
Article
Similar
MEDLINE
...
LILACS
LIS